Development of a protective dermal drug delivery system for therapeutic DNAzymes
- 1 February 2015
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 479 (1) , 150-158
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (03FH0313)
This publication has 29 references indexed in Scilit:
- Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)The Lancet, 2013
- Modeling the human skin barrier — Towards a better understanding of dermal absorptionAdvanced Drug Delivery Reviews, 2013
- DNAzyme Targeting c- jun Suppresses Skin Cancer GrowthScience Translational Medicine, 2012
- Mechanisms and emerging functions of DNA degradation in the epidermisFrontiers in Bioscience-Landmark, 2012
- Non-Viral Nucleic Acid Delivery: Key Challenges and Future DirectionsCurrent Drug Delivery, 2011
- Actinic keratosesCancer, 2009
- Effect of charge density on the formation and salt stability of polyelectrolyte complexesMacromolecular Chemistry and Physics, 2002
- Target site selection for an RNA-cleaving catalytic DNANature Biotechnology, 1999
- High Yield Incorporation of Plasmid DNA within Liposomes: Effect on DNA Integrity and Transfection EfficiencyJournal of Drug Targeting, 1996
- A DNA enzyme that cleaves RNAChemistry & Biology, 1994